123 results on '"Bryan, Christopher F."'
Search Results
2. Abstract 723: Cortical Bone Derived Stem Cells Modulates T Cell Response After Myocardial Injury
3. Sharing kidneys across donor-service area boundaries with sensitized candidates can be influenced by HLA C
4. Renal graft survival is not influenced by a positive flow B-cell crossmatch
5. Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis
6. The risk for Chagasʼ disease in the Midwestern United States organ donor population is low
7. ABO blood group influences a candidateʼs likelihood of receiving an HLA zero antigen mismatch kidney
8. Cold ischaemia time added to kidneys can be minimized by completing the final cross-match before organs are taken from the operating room
9. HLA Points Assigned in Cadaveric Kidney Allocation Should Be Revisited: An Analysis of HLA Class II Molecularly Typed Patients and Donors
10. Flow cytometry beads rather than the antihuman globulin method should be used to detect HLA Class I IgG antibody (PRA) in cadaveric renal regraft candidates
11. Increased Access to Transplantation for Blood Group B Cadaveric Waiting List Candidates by Using A2 Kidneys: Time for a New National System?
12. Improved Graft Survival in Cadaveric Renal Retransplantation by Flow Crossmatching
13. The Immune System in Hereditary Hemochromatosis: A Quantitative and Functional Assessment of the Cellular Arm
14. The Immunogenetics of Hereditary Hemochromatosis
15. Current experience with renal transplantation across the ABO barrier
16. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm
17. Donor-specific antibodies present at the time of kidney transplantation in immunologically unmodified patients increase the risk of acute rejection
18. Differential inhibition of the MLR by iron: Association with HLA phenotype
19. Thermostable erythrocyte rosette-forming lymphocytes in hereditary hemochromatosis. I. Identification in peripheral blood
20. When Will Real Benefits for Minority Patients Be Realized With A2→B Transplants?
21. A New Role for the Virtual Crossmatch in Kidney Allograft Reuse
22. 75-P: IVIg reduces the risk of early vascular graft loss in patients with a remote positive HLA class I IgG donor-specific crossmatch
23. Implications of ABO Error Rates in Proficiency Testing for Solid Organ Transplantation
24. Improving Access to Kidney Transplantation without Decreasing Graft Survival: Long-Term Outcomes of Blood Group A2/A2B Deceased Donor Kidneys in B Recipients
25. COLD ISCHEMIA TIME: AN INDEPENDENT PREDICTOR OF INCREASED HLA CLASS I ANTIBODY PRODUCTION AFTER REJECTION OF A PRIMARY CADAVERIC RENAL ALLOGRAFT1
26. EFFECT OF DONOR BRAIN DEATH DURATION ON GRAFT OUTCOME.
27. A METHOD COMPARISON FOR PERFORMING THE ANTI-A TITER ASSAY FOR TRANSPLANTATION OF A2 KIDNEYS INTO B AND O PATIENTS.
28. DOES CREG MATCHING REDUCE THE ODDS OF A POSITIVE CROSSMATCH?
29. TRANSPLANTATION RATE OF THE BLOOD GROUP B WAITING LIST IS INCREASED BY USING A2 AND A2B KIDNEYS1
30. LONG-TERM GRAFT SURVIVAL IS IMPROVED IN CADAVERIC RENAL RETRANSPLANTATION BY FLOW CYTOMETRIC CROSSMATCHING1
31. INFLUENCE OF THE Rh (D) BLOOD GROUP SYSTEM ON GRAFT SURVIVAL IN RENAL TRANSPLANTATION
32. TEN-YEAR EXPERIENCE IN TRANSPLANTATION OF A2KIDNEYS INTO B AND O RECIPIENTS1
33. DETECTION OF HLA IgG ANTIBODIES BY TWO ENZYME-LINKED IMMUNOASSAYS, SOLUBILIZED HLA CLASS I AND PRA-STAT
34. Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: A U.S. National Collaborative Study
35. Solubilized HLA class I antigen enzyme-linked immunoassay to identify HLA-typing reagents
36. COLD ISCHEMIA TIME: AN INDEPENDENT PREDICTOR OF INCREASED HLA CLASS I ANTIBODY PRODUCTION AFTER REJECTION OF A PRIMARY CADAVERIC RENAL ALLOGRAFT1.
37. Genetic studies in multiple myeloma. 1. Association with HLA-Cw5.
38. TEN-YEAR EXPERIENCE IN TRANSPLANTATION OF A2KIDNEYS INTO B AND O RECIPIENTS.
39. HLA-DR AND DQ TYPING BY POLYMERASE CHAIN REACTION USING SEQUENCE-SPECIFIC PRIMER MIXES REDUCES THE INCIDENCE OF PHENOTYPIC HOMOZYGOSITY (BLANKS) OVER SEROLOGY.
40. TRANSPLANTATION RATE OF THE BLOOD GROUP B WAITING LIST IS INCREASED BY USING A2AND A2B KIDNEYS1
41. The Immunoregulatory Nature of Iron. II. Lymphocyte Surface Marker Expression
42. Serum Inhibitor in Systemic Lupus Erythematosus Associated With Aplastic Anemia
43. The immunoregulatory nature of iron
44. Thermostable Erythrocyte Rosettes in Chronic Renal Failure and Allograft Rejection
45. UPDATED REPORT ON THE OPTN/UNOS NATIONAL VOLUNTARY VARIANCE TO ALLOCATE A2/A2B DECEASED DONOR KIDNEYS TO BLOOD GROUP B CANDIDATES.
46. A METHOD COMPARISON FOR PERFORMING THE ANTI-A TITER ASSAY FOR TRANSPLANTATION OF A2 KIDNEYS INTO B AND O PATIENTS.
47. A METHOD COMPARISON FOR PERFORMING THE ANTIA TITER ASSAY FOR TRANSPLANTATION OF A2KIDNEYS INTO B AND O PATIENTS.
48. DETECTION OF HLA IgG ANTIBODIES BY TWO ENZYMELINKED IMMUNOASSAYS, SOLUBILIZED HLA CLASS I AND PRASTAT
49. The effect of cyclomunine on the in vitro responsiveness of rat and canine lymphocytes, and on rat cardiac allograft survival
50. When will real benefits for minority patients be realized with A2-->B transplants?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.